Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hopper

Showing results (591-600 of 1,167) with videos related to

Pageof 117
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|October 29, 2020
Breast Cancer Chemoprevention: Use and Views of Australian Women and Their CliniciansCourtney Macdonald, Christobel M Saunders, Louise A Keogh, et al.
JNCI Cancer Spectrum|April 2, 2024
Association of breast cancer with quantitative mammographic density measures for women receiving contrast-enhanced mammographyGordon P Watt, Krishna N Keshavamurthy, Tuong L Nguyen, et al.
Familial Cancer|January 5, 2013
Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything?Mark Clendenning, Michael D Walsh, Judith Balmana Gelpi, et al.
Clinical Chemistry|April 30, 2014
Early detection of fragile X syndrome: applications of a novel approach for improved quantitative methylation analysis in venous blood and newborn blood spotsYoshimi Inaba, Charles E Schwartz, Quang M Bui, et al.
Expert Reviews in Molecular Medicine|July 2, 2015
Detection of skewed X-chromosome inactivation in Fragile X syndrome and X chromosome aneuploidy using quantitative melt analysisDavid E Godler, Yoshimi Inaba, Charles E Schwartz, et al.
Cancers|March 25, 2022
Familial Aspects of Mammographic Density Measures Associated with Breast Cancer RiskTuong L Nguyen, Shuai Li, James G Dowty, et al.
Journal of the National Cancer Institute|June 8, 1999
Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty yearsA B Spurdle, G S Dite, X Chen, et al.
JNCI Cancer Spectrum|May 12, 2021
Prospective Evaluation of the Addition of Polygenic Risk Scores to Breast Cancer Risk ModelsSherly X Li, Roger L Milne, Tu Nguyen-Dumont, et al.
Journal of the National Cancer Institute|January 24, 2018
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population WomenRanjit Manchanda, Shreeya Patel, Vladimir S Gordeev, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 15, 2020
A New Comprehensive Colorectal Cancer Risk Prediction Model Incorporating Family History, Personal Characteristics, and Environmental FactorsYingye Zheng, Xinwei Hua, Aung K Win, et al.
Pageof 117

Showing results (591-600 of 1,167) with videos related to

Sort By:
Pageof 117
Cancer Prevention Research (Philadelphia, Pa.)|October 29, 2020
Breast Cancer Chemoprevention: Use and Views of Australian Women and Their CliniciansCourtney Macdonald, Christobel M Saunders, Louise A Keogh, et al.
JNCI Cancer Spectrum|April 2, 2024
Association of breast cancer with quantitative mammographic density measures for women receiving contrast-enhanced mammographyGordon P Watt, Krishna N Keshavamurthy, Tuong L Nguyen, et al.
Familial Cancer|January 5, 2013
Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything?Mark Clendenning, Michael D Walsh, Judith Balmana Gelpi, et al.
Clinical Chemistry|April 30, 2014
Early detection of fragile X syndrome: applications of a novel approach for improved quantitative methylation analysis in venous blood and newborn blood spotsYoshimi Inaba, Charles E Schwartz, Quang M Bui, et al.
Expert Reviews in Molecular Medicine|July 2, 2015
Detection of skewed X-chromosome inactivation in Fragile X syndrome and X chromosome aneuploidy using quantitative melt analysisDavid E Godler, Yoshimi Inaba, Charles E Schwartz, et al.
Cancers|March 25, 2022
Familial Aspects of Mammographic Density Measures Associated with Breast Cancer RiskTuong L Nguyen, Shuai Li, James G Dowty, et al.
Journal of the National Cancer Institute|June 8, 1999
Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty yearsA B Spurdle, G S Dite, X Chen, et al.
JNCI Cancer Spectrum|May 12, 2021
Prospective Evaluation of the Addition of Polygenic Risk Scores to Breast Cancer Risk ModelsSherly X Li, Roger L Milne, Tu Nguyen-Dumont, et al.
Journal of the National Cancer Institute|January 24, 2018
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population WomenRanjit Manchanda, Shreeya Patel, Vladimir S Gordeev, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 15, 2020
A New Comprehensive Colorectal Cancer Risk Prediction Model Incorporating Family History, Personal Characteristics, and Environmental FactorsYingye Zheng, Xinwei Hua, Aung K Win, et al.
Pageof 117